In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Glaxo purchases DNA vaccine licenses from PowderJect
PowderJect and GlaxoSmithKline initiate clinical study
PowderJect DNA Vaccine Achieves Protective Immunity
Chiron Vaccines Spins Out Powder Injection Therapeutic DNA Vaccine Programs to PowderMed Ltd
PowderJect completes acquisition of Medeva Vaccines
BioSante Announces Positive Vaccine Adjuvant Results